The large volume parenteral market is growing as hospitals and healthcare providers increase their use of intravenous therapies for hydration, drug delivery, nutrition, and critical-care treatment. The market was valued at USD 10.9 billion in 2024 and is projected to reach USD 15.7 billion by 2035, expanding at a CAGR of 3.4%. 1077 Large volume parenterals, commonly referred to as LVPs, are...